Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 443

1.

Higher levels of the anti-inflammatory protein CC10 are associated with improvement in bronchial dysplasia and sputum cytometric assessment in individuals at high risk for lung cancer.

Chen J, Lam S, Pilon A, McWilliams A, Macaulay C, Szabo E.

Clin Cancer Res. 2008 Mar 1;14(5):1590-7. doi: 10.1158/1078-0432.CCR-07-4066.

2.

The association between the anti-inflammatory protein CC10 and smoking status among participants in a chemoprevention trial.

Chen J, Lam S, Pilon A, McWilliams A, Melby J, Szabo E.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):577-83.

3.

Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.

Jeanmart M, Lantuejoul S, Fievet F, Moro D, Sturm N, Brambilla C, Brambilla E.

Clin Cancer Res. 2003 Jun;9(6):2195-203.

4.

Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers.

Shijubo N, Itoh Y, Yamaguchi T, Shibuya Y, Morita Y, Hirasawa M, Okutani R, Kawai T, Abe S.

Eur Respir J. 1997 May;10(5):1108-14.

5.

High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.

Kennedy TC, Franklin WA, Prindiville SA, Cook R, Dempsey EC, Keith RL, Hirsch FR, Merrick TA, Shroyer KR, Petty TL, Byers T, Bunn PA Jr, Miller YE.

Lung Cancer. 2005 Aug;49(2):187-91.

PMID:
16022912
6.

Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories.

Kennedy TC, Proudfoot SP, Franklin WA, Merrick TA, Saccomanno G, Corkill ME, Mumma DL, Sirgi KE, Miller YE, Archer PG, Prochazka A.

Cancer Res. 1996 Oct 15;56(20):4673-8.

7.

Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.

Prindiville SA, Byers T, Hirsch FR, Franklin WA, Miller YE, Vu KO, Wolf HJ, Barón AE, Shroyer KR, Zeng C, Kennedy TC, Bunn PA.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):987-93.

8.

Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.

Crowell RE, Gilliland FD, Temes RT, Harms HJ, Neft RE, Heaphy E, Auckley DH, Crooks LA, Jordan SW, Samet JM, Lechner JF, Belinsky SA.

Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):631-7.

9.

Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.

Merrick DT, Kittelson J, Winterhalder R, Kotantoulas G, Ingeberg S, Keith RL, Kennedy TC, Miller YE, Franklin WA, Hirsch FR.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2281-8.

10.

Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity.

Byers T, Wolf HJ, Franklin WA, Braudrick S, Merrick DT, Shroyer KR, Hirsch FR, Zeng C, Barón AE, Bunn PA, Miller YE, Kennedy TC.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):158-62. doi: 10.1158/1055-9965.EPI-07-0436.

11.

Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer.

Breuer RH, Snijders PJ, Sutedja TG, v d Linden H, Risse EK, Meijer CJ, Postmus PE, Smit EF.

Lung Cancer. 2003 May;40(2):165-72.

PMID:
12711117
12.

Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.

Hirsch FR, Prindiville SA, Miller YE, Franklin WA, Dempsey EC, Murphy JR, Bunn PA Jr, Kennedy TC.

J Natl Cancer Inst. 2001 Sep 19;93(18):1385-91.

PMID:
11562389
14.

Sex-related differences in bronchial epithelial changes associated with tobacco smoking.

Lam S, leRiche JC, Zheng Y, Coldman A, MacAulay C, Hawk E, Kelloff G, Gazdar AF.

J Natl Cancer Inst. 1999 Apr 21;91(8):691-6.

PMID:
10218506
15.

Histological types and significance of bronchial epithelial dysplasia.

Wang GF, Lai MD, Yang RR, Chen PH, Su YY, Lv BJ, Sun LP, Huang Q, Chen SZ.

Mod Pathol. 2006 Mar;19(3):429-37.

16.

Expression of p53 in preneoplastic and early neoplastic bronchial lesions.

Martin B, Verdebout JM, Mascaux C, Paesmans M, Rouas G, Verhest A, Ninane V, Sculier JP.

Oncol Rep. 2002 Mar-Apr;9(2):223-9.

PMID:
11836584
17.

CC10 mRNA and protein expression in Clara cells of CD-1 mice following exposure to styrene or its metabolites styrene oxide or 4-vinylphenol.

Harvilchuck JA, Zurbrugg RJ, Carlson GP.

Toxicol Lett. 2008 Dec 15;183(1-3):28-35. doi: 10.1016/j.toxlet.2008.09.010.

PMID:
18926891
18.

Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.

Kettunen E, Salmenkivi K, Vuopala K, Toljamo T, Kuosma E, Norppa H, Knuutila S, Kaleva S, Huuskonen MS, Anttila S.

Lung Cancer. 2006 Nov;54(2):169-76.

PMID:
16935392
19.

Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.

Lam S, Xu X, Parker-Klein H, Le Riche JC, Macaulay C, Guillaud M, Coldman A, Gazdar A, Lotan R.

Int J Oncol. 2003 Dec;23(6):1607-13.

PMID:
14612933
20.

Overexpression of CC10 modifies neoplastic potential in lung cancer cells.

Szabo E, Goheer A, Witschi H, Linnoila RI.

Cell Growth Differ. 1998 Jun;9(6):475-85.

Supplemental Content

Support Center